Brief: Hyloris Pharmaceuticals Broadens Pipeline With New Product Candidate In Burning Mouth Syndrome

Hyloris Pharmaceuticals SA

21/12/2023 17:32

Dec 21 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * HYLORIS BROADENS PIPELINE WITH NEW PRODUCT CANDIDATE IN
BURNING
MOUTH SYNDROME
    * EQUAL PARTNERSHIP WITH AFT PHARMACEUTICALS FOR DEVELOPMENT
OF A
NOVEL LOCALLY-ACTING PRODUCT CANDIDATE IN BURNING MOUTH SYNDROME
(HY-090)
    * STRENGTHENING STRATEGIC PARTNERSHIP WITH AFT
PHARMACEUTICALS
FOLLOWING SUCCESS OF MAXIGESIC® IV COLLABORATION
    * PARTIES ARE JOINTLY RESPONSIBLE FOR COMMERCIALIZATION IN
UNITED
STATES

Source text for Eikon:  ID:nGNE7gTR20 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))